Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-01-28 @ 5:48 PM
Study NCT ID:
NCT03966118
Status:
UNKNOWN
Last Update Posted:
2019-06-03
First Post:
2019-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma
Sponsor:
Organization: